BiomX Inc. Insider Transactions
BiomX Inc. Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
OrbiMed Israel BioFund GP Limited Partnership
10 percent owner |
Sell | 24,344 @ $0.38 | $9,280 | 13,773,653 | 05/15/2024 | 05/20/2024 | |
OrbiMed Israel BioFund GP Limited Partnership
10 percent owner |
Buy | 2,163,500 @ $0.23 | $499,985 | 2,163,500 | 03/15/2024 | 03/19/2024 | |
OrbiMed Israel BioFund GP Limited Partnership
10 percent owner |
Buy | 4,327 @ $0.00 | $0 | 4,327 | 03/15/2024 | 03/19/2024 | |
Oron Assaf
Chief Business Officer |
Sell | 5,444 @ $0.40 | $2,178 | 5,470 | 11/29/2023 | 12/01/2023 | |
Oron Assaf
Chief Business Officer |
Sell | 3,414 @ $0.35 | $1,195 | 2,056 | 11/29/2023 | 12/01/2023 | |
Oron Assaf
Chief Business Officer |
Sell | 2,056 @ $0.34 | $699 | 0 | 11/29/2023 | 12/01/2023 | |
Oron Assaf
Chief Business Officer |
Buy | 3,192 @ $0.27 | $872 | 10,914 | 05/22/2023 | 05/24/2023 | |
Oron Assaf
Chief Business Officer |
Buy | 6,521 @ $0.28 | $1,832 | 7,722 | 05/19/2023 | 05/22/2023 | |
Oron Assaf
Chief Business Officer |
Buy | 1,201 @ $0.27 | $328 | 1,201 | 05/18/2023 | 05/22/2023 | |
OrbiMed Israel BioFund GP Limited Partnership
10 percent owner |
Buy | 348,000 @ $0.25 | $85,260 | 3,161,489 | 02/27/2023 | 03/17/2023 | |
OrbiMed Israel BioFund GP Limited Partnership
10 percent owner |
Buy | 1,789,959 @ $0.24 | $436,750 | 1,789,959 | 02/27/2023 | 03/17/2023 |
BiomX Inc. FAQ's
The list of insiders at BiomX Inc. includes OrbiMed Israel BioFund GP Limited Partnership.
Insiders have sold a total of 24,344 BiomX Inc. shares in the last 12 months for a total of 9,280 sold.
The following insiders have sold BiomX Inc. shares in the last 12 months: OrbiMed Israel BioFund GP Limited Partnership ($9,280),
Insiders have purchased a total of 2.17 M BiomX Inc. shares in the last 12 months for a total of 499,985.
The following insiders have purchased BiomX Inc. shares in the last 12 months: OrbiMed Israel BioFund GP Limited Partnership ($499,985),